Different Volumes of Erector Spinae Plane Block for Breast Surgery
Breast Cancer, Breast Neoplasms, Breast Diseases
About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring Mastectomy and axillary dissection surgery, Postoperative pain management, Erector Spinae Plane Block
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) classification I-II
- Scheduled for mastectomy and axillary dissection surgery under general anesthesia
Exclusion Criteria:
- anticoagulant treatment,
- known local anesthetic allergy,
- infected skin around the block site,
- pregnancy or breast-feeding,
- back abnormalities
Sites / Locations
- Istanbul Medipol University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Group 30 = 30 ml of Erector spinae plane block group
Group 20 = 20 ml of Erector spinae plane block group
In group 30 ml, ESPB will be performed with patients in the lateral decubitus position while the surgical site up. US probe will be placed 2-3 cm lateral to the T4 transvers process. The block needle will be inserted cranio-caudal direction and then for correction of the needle 5 ml saline will be injected deep into the erector spina muscle fascia. Following confirmation of the correct position of the needle 30 ml %0.25 bupivacaine will be administered for block.
In group ESPB, ESPB will be performed with patients in the lateral decubitus position while the surgical site up. US probe will be placed 2-3 cm lateral to the T4 transvers process. The block needle will be inserted cranio-caudal direction and then for correction of the needle 5 ml saline will be injected deep into the erector spina muscle fascia. Following confirmation of the correct position of the needle 20 ml %0.25 bupivacaine will be administered for block.